These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 11302961)

  • 21. Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis.
    Nguyen TM; Daubard M; Le Gall C; Larger M; Lachaux A; Boulieu R
    Ther Drug Monit; 2010 Aug; 32(4):433-7. PubMed ID: 20479703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azathioprine: state of the art in inflammatory bowel disease.
    Sandborn WJ
    Scand J Gastroenterol Suppl; 1998; 225():92-9. PubMed ID: 9515759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease.
    Lowry PW; Franklin CL; Weaver AL; Pike MG; Mays DC; Tremaine WJ; Lipsky JJ; Sandborn WJ
    Gut; 2001 Nov; 49(5):665-70. PubMed ID: 11600469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels.
    Angelberger S; Schaeffeler E; Teml A; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR; Schwab M; Reinisch W
    Inflamm Bowel Dis; 2013 Mar; 19(3):590-8. PubMed ID: 23388543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercaptopurine therapy.
    Cuffari C; Seidman EG; Latour S; Théorêt Y
    Can J Physiol Pharmacol; 1996 May; 74(5):580-5. PubMed ID: 8884023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous azathioprine in severe ulcerative colitis: a pilot study.
    Mahadevan U; Tremaine WJ; Johnson T; Pike MG; Mays DC; Lipsky JJ; Sandborn WJ
    Am J Gastroenterol; 2000 Dec; 95(12):3463-8. PubMed ID: 11151878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of pharmacogenetics, enzymatic phenotyping, and metabolite monitoring to guide treatment with azathioprine in patients with systemic lupus erythematosus.
    Askanase AD; Wallace DJ; Weisman MH; Tseng CE; Bernstein L; Belmont HM; Seidman E; Ishimori M; Izmirly PM; Buyon JP
    J Rheumatol; 2009 Jan; 36(1):89-95. PubMed ID: 19040311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic drug monitoring in patients with inflammatory bowel disease and established azathioprine therapy.
    Gilissen LP; Derijks LJ; Bos LP; Bus PJ; Hooymans PM; Engels LG
    Clin Drug Investig; 2004; 24(8):479-86. PubMed ID: 17523708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.
    Sparrow MP; Hande SA; Friedman S; Cao D; Hanauer SB
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):209-14. PubMed ID: 17296529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 6-thioguanine--efficacy and safety in chronic active Crohn's disease.
    Herrlinger KR; Kreisel W; Schwab M; Schoelmerich J; Fleig WE; Ruhl A; Reinshagen M; Deibert P; Fellermann K; Greinwald R; Stange EF
    Aliment Pharmacol Ther; 2003 Feb; 17(4):503-8. PubMed ID: 12622758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring associations of 6-thioguanine nucleotide levels and other predictive factors with therapeutic response to azathioprine in pediatric patients with IBD using multilevel analysis.
    Nguyen TV; Vu DH; Nguyen TM; Lachaux A; Boulieu R
    Inflamm Bowel Dis; 2013 Oct; 19(11):2404-10. PubMed ID: 24013359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azathioprine: when less is more.
    Duley JA; Florin TH
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1317-9. PubMed ID: 18853992
    [No Abstract]   [Full Text] [Related]  

  • 33. Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?
    Heerasing NM; Ng JF; Dowling D
    Intern Med J; 2016 Apr; 46(4):465-9. PubMed ID: 26425841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of glutathione-s-transferase m1 reduces azathioprine metabolite concentrations in young patients with inflammatory bowel disease.
    Stocco G; Cuzzoni E; De Iudicibus S; Franca R; Favretto D; Malusà N; Londero M; Cont G; Bartoli F; Martelossi S; Ventura A; Decorti G
    J Clin Gastroenterol; 2014 Jan; 48(1):43-51. PubMed ID: 23787247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.
    Spencer E; Norris E; Williams C; Dubinsky MC
    Inflamm Bowel Dis; 2019 Jan; 25(1):142-149. PubMed ID: 29920603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease.
    Sandborn WJ; Van O EC; Zins BJ; Tremaine WJ; Mays DC; Lipsky JJ
    Gastroenterology; 1995 Dec; 109(6):1808-17. PubMed ID: 7498645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel assay to improve therapeutic drug monitoring of thiopurines in inflammatory bowel disease.
    Vikingsson S; Andersson D; Almer S; Peterson C; Hindorf U
    J Crohns Colitis; 2014 Dec; 8(12):1702-9. PubMed ID: 25239576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indicators of clinical response to treatment with six-mercaptopurine or azathioprine in patients with inflammatory bowel disease.
    Achkar JP; Stevens T; Easley K; Brzezinski A; Seidner D; Lashner B
    Inflamm Bowel Dis; 2004 Jul; 10(4):339-45. PubMed ID: 15475740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.